Title : Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin.

Pub. Date : 2008 Feb

PMID : 18303430






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin. Celecoxib cadherin 1 Homo sapiens